KIRK COWARD: Open Payments
NPI 1356638290 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 47 payments from 11 companies in 2025. Trend: 2023 $264 · 2024 $416 · 2025 $1,103
Food & beverage: $1,103
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $409 |
| AstraZeneca Pharmaceuticals LP | 11 | $403 |
| Biogen, Inc. | 6 | $134 |
| Novo Nordisk Inc | 2 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: AIRSUPRA, UBRELVY, FARXIGA, QULIPTA, ZURZUVAE, VRAYLAR, BREZTRI, JOURNAVX.
Industry payments across AR — which companies pay providers there.
